Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Dorothee Oberdhan's publication output changed over time?
ScholarIQpublication output · 2013–2024
Output grew0% over the shown period — from 1 works in 2013 to 1 in 2024.
1
2
1
1
3
1
1
1
1
201320152017201920202021202220232024
What are the most-cited papers on Dorothee Oberdhan?
ScholarIQmost cited works
Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease
Wendy E. Boertien, Esther Meijer, Paul E. de Jong, Stephan J. L. Bakker, Frank S. Czerwiec, Joachim Struck, Dorothee Oberdhan, Susan E. Shoaf, Holly B. Krasa, Ron T. Gansevoort
Kidney International. 201391 CitationsOPEN ACCESS
Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function
Wendy E. Boertien, Esther Meijer, Paul E. de Jong, Gert J. Ter Horst, Remco J. Renken, Eric J. van der Jagt, Peter Kappert, John Ouyang, Gerwin E. Engels, Willem van Oeveren, Joachim Struck, Frank S. Czerwiec, Dorothee Oberdhan, Holly B. Krasa, Ron T. Gansevoort
American Journal of Kidney Diseases. 201582 CitationsOPEN ACCESS
Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer’s Disease Interventions
Pei‐Jung Lin, Brittany D’Cruz, Ashley A. Leech, Peter J. Neumann, Myrlene Sanon Aigbogun, Dorothee Oberdhan, Tara A. Lavelle
PharmacoEconomics. 201966 CitationsOPEN ACCESS
Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology–Polycystic Kidney Disease (SONG-PKD) Consensus Workshop
Yeoungjee Cho, Allison Tong, Jonathan C. Craig, Reem A. Mustafa, Arlene B. Chapman, Ronald D. Perrone, Curie Ahn, Kevin Fowler, Vicente E. Torres, Ron T. Gansevoort, Albert Ong, Helen Coolican, Juliana Tze‐Wah Kao, Tess Harris, Talia Gutman, Jenny I. Shen, Andrea K. Viecelli, David W. Johnson, Eric Au, Ragada El-Damanawi, Charlotte Logeman, Angela Ju, Karine Manera, Michel Chonchol, Dwight Odland, David Baron, York Pei, Bénédicte Sautenet, Anjay Rastogi, Ankit Sharma, Gopala K. Rangan, Adeera Levin, Alan S.L. Yu, Albert Ong, Aliza Thompson, Allison Tong, Amanda Baumgart, Amélie Bernier-Jean, Amy Kelly, Andrea Viecelli, Andrew Mallett, Angela Ju, Angela Yee‐Moon Wang, Anjay Rastog, Ankit Sharma, Annie-Claire Nadeau-Fredette, Arlene B. Chapman, Armando Teixeira‐Pinto, Ayano Kelly, Barbara S. Gillespie, Bénédicte Sautenet, B. Canaud, Braden Manns, Brenda R. Hemmelgarn, Camilla S. Hanson, Carmel Hawley, Carol A. Pollock, Charlotte Logeman, Chia‐Ter Chao, Claudia Rutherford, Curie Ahn, Daniel Sumpton, David A. Harris, David W. Johnson, David Wheeler, Djalila Mekahli, Dónal O’Donoghue, Dorien Peters, Dorothee Oberdhan, Elena Balovlenkov, Emma O’Lone, Eric Au, Francesca Tentori, Frank S. Czerwiec, Frederic F. Rahbari-Oskoui, Gopi Rangan, Gregory Germino, Hayne Park, Htay Htay, Hyunjin Ryu, Jenna M. Norton, Jenny I. Shen, John Gill, Jonathan C. Craig, Juliana Kao, Kai‐Uwe Eckardt, Karine Manera, Kim Linh Van, Lisa M. Guay‐Woodford, Mahesh Krishnan, Marie C. Hogan, Martin Howell, Meyeon Park, Michal Mrug, Michel Chonchol, Michelle H. T. Ta, Nicole Evangelidis, Peter Harris, Peter Tugwell, Pranav S. Garimella
American Journal of Kidney Diseases. 202054 CitationsOPEN ACCESS
Development of the Autosomal Dominant Polycystic Kidney Disease Impact Scale: A New Health-Related Quality-of-Life Instrument
Dorothee Oberdhan, Jason C. Cole, Holly B. Krasa, Rebecca Cheng, Frank S. Czerwiec, Ron D. Hays, Arlene B. Chapman, Ronald D. Perrone
American Journal of Kidney Diseases. 201750 CitationsOPEN ACCESS
Related on ScholarIQ
Pharmaceutical Product Development (United States)
Institution
Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease
Paper
Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function
Paper
Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer’s Disease Interventions
Paper
Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology–Polycystic Kidney Disease (SONG-PKD) Consensus Workshop
Paper
Development of the Autosomal Dominant Polycystic Kidney Disease Impact Scale: A New Health-Related Quality-of-Life Instrument
Paper